Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02620449 · ClinicalTrials.gov registry record · NA
Impact of Lowering Phosphate Additive Intake on Metabolism and Cardiovascular Health in Community-Living Adults
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02620449 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 50 participants.
The verdict
NCT02620449, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of the study is to learn more about how common food additives can affect phosphorus metabolism in people with normal kidney function and people with chronic kidney disease.
Interventions
- OTHER Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2015-08-28 |
| Est. Completion | 2020-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02620449
The ClinicalTrials.gov registry entry for NCT02620449 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diet is the first listed.
NCT02620449 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02620449 about?
NCT02620449 is a clinical study titled "Impact of Lowering Phosphate Additive Intake on Metabolism and Cardiovascular Health in Community-Living Adults". The purpose of the study is to learn more about how common food additives can affect phosphorus metabolism in people with normal kidney function and people with chronic kidney disease.
What is the current status of trial NCT02620449?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2015-08-28. Estimated completion is 2020-03-30.
What interventions are being tested in trial NCT02620449?
The interventions under investigation include: Diet (OTHER).
Who is sponsoring clinical trial NCT02620449?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.